Suppr超能文献

法林洛尔的药代动力学II. 白化兔眼内给药和静脉注射法林洛尔后在组织和器官中的吸收、分布及消除

Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.

作者信息

Andermann G, Guggenbuhl P, de Burlet G, Himber J

出版信息

Methods Find Exp Clin Pharmacol. 1989 Dec;11(12):747-54.

PMID:2576299
Abstract

The absorption, distribution and elimination of falintolol maleate was studied in various ocular and extraocular tissues and organs following ocular instillation, intravenous injection of a 0.5% 14C-falintolol ophthalmic solution and repeated ocular instillations of a 1% non-labeled falintolol ophthalmic solution into albino New Zealand rabbits. Falintolol was distributed in all studied tissues and organs after both routes of administration. After ocular instillation, levels of total radioactivity were distinctly higher in ocular tissues than after intravenous injection. Thus, the level was 475 times more important in cornea, 72 times in aqueous humor and 36 times in iris and ciliary body after ocular instillation. On the other hand, levels of total radioactivity in extraocular tissues and organs were 30-50% higher after intravenous injection compared to ocular instillation of the same dose. Peak levels of total radioactivity were generally achieved between 30 min and 1 h after ocular instillation, while 1.5 h after intravenous injection an increase in the declining part of the curve occurred. This increase, characteristic of an enterohepatic reabsorption, was also observed in blood and plasma 1 h after intravenous injection. Urinary elimination was the major means of excretion since 79.6% of total radioactivity was found in urine 6 h after intravenous injection and 74.5% 12 h after ocular instillation. But after ocular instillation, only 5% was excreted as unchanged falintolol. Whatever the route of administration, after single or repeated application, no drug accumulation was evident.

摘要

在白化新西兰兔眼内滴注、静脉注射0.5%的14C-法利洛尔滴眼液以及重复眼内滴注1%的未标记法利洛尔滴眼液后,研究了马来酸法利洛尔在各种眼内和眼外组织及器官中的吸收、分布和消除情况。两种给药途径后,法利洛尔均分布于所有研究的组织和器官中。眼内滴注后,眼组织中的总放射性水平明显高于静脉注射后。因此,眼内滴注后,角膜中的水平高475倍,房水中高72倍,虹膜和睫状体中高36倍。另一方面,与相同剂量的眼内滴注相比,静脉注射后眼外组织和器官中的总放射性水平高30 - 50%。眼内滴注后,总放射性的峰值水平通常在30分钟至1小时之间达到,而静脉注射后1.5小时,曲线下降部分出现增加。这种增加是肠肝循环重吸收的特征,在静脉注射后1小时的血液和血浆中也观察到。尿排泄是主要的排泄途径,因为静脉注射后6小时尿液中发现总放射性的79.6%,眼内滴注后12小时发现74.5%。但眼内滴注后,只有5%以未改变的法利洛尔形式排泄。无论给药途径如何,单次或重复应用后,均未发现明显的药物蓄积。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验